Reiter’s syndrome


InjuryDiseasesNutritionPoison
SymptomsSurgeryTestSpecial Topic
Overview Symptoms Treatment Prevention

Reiter's syndrome - view of the feet
Reiter's syndrome - view of the feet
Alternative Names

Reactive arthritis


Treatment

The objective of treatment is to alleviate the symptoms associated with the syndrome and to treat any underlying infection. In general, the conjunctivitis and skin lesions associated with the syndrome do not require treatment, and will resolve on their own.

Any underlying infection should be treated with antibiotics, although this has not been shown to affect the course of the arthritis. The arthritis is treated with nonsteroidal anti-inflammatory medications (NSAIDS) and pain relievers. These medications are tolerated better when they are taken with food. Local administration of corticosteroids may help relieve the symptoms associated with persistent inflammation in one joint.



Physical therapy exercises for specifically involved areas and the back are helpful in relieving pain, maintaining mobility of the affected joints, and maintaining muscular strength. Adjustments in occupational tasks may be required if lifting or strenuous use of the back is required.

Therapy to suppress the immune system may be considered for individuals with a severe case of the disease, but this treatment is not used in most people because of the toxic side effects.


Support Groups


Expectations (prognosis)

The illness may resolve in 3 to 4 months, but up to one-half of those affected experience recurrences of the arthritis or other symptoms of the syndrome over a period of several years. The condition may become chronic.


Complications

Calling your health care provider

Call for an appointment with your health care provider if symptoms of Reiter's syndrome develop.



Review Date: 04/20/2005
Reviewed By: Stanford Peng, M.D., Ph.D., Division of Rheumatology, Washington University School of Medicine, St. Louis, MO. Review provided by VeriMed Healthcare Network.

Find a Therapist

Powered by Psychology Today


PR Newswire